Teprotumumab appears effective for patients with chronic thyroid eye disease
Investigators assessed the use of teprotumumab for patients with chronic thyroid eye disease (TED) with a low clinical activity score (CAS). Source: AAO
- Posted on: Oct 4 2021
- Leave a response